Tuesday, December 29, 2020
DW Healthcare Partners a healthcare-focused private equity firm, announced today the closing of its previously disclosed sale of Z-Medica to Teleflex Incorporated. Z-Medica, a portfolio company of DW Healthcare Partners and Linden Capital Partners ("Linden"), is a leading manufacturer and marketer of patented hemostatic products that enable healthcare providers, military personnel, and first responders to control bleeding and hemorrhaging.
DWHP first invested in Z-Medica in September of 2012 and realized substantial growth in the business through channel diversification and new product development. In September 2017, DWHP sold majority control of the asset to Linden. DWHP representatives Doug Schillinger and Stephen Fanning remained on the Board of Directors, partnering with Linden and Z-Medica management to build the Company into the leading hemostatic products company that it is today.
"It has been extremely edifying to see Z-Medica transform over the years. We took what was essentially just a product line in 2012 and we built an exciting and diversified company out of it," said Doug Schillinger, Managing Director at DWHP. "Five years later, we agreed to stay involved and partner with Linden to launch the QuickClot Control+® product line which has become a staple in U.S. trauma centers."
Eric Compton, CEO of Z-Medica said, "DWHP's continued involvement in the business has been critical to our ongoing success as they have provided important historical context, as well as continued guidance. I would like to thank Doug and Steve for their tremendous insight and partnership as Board members."
Truist Securities acted as financial advisor to Z-Medica and Kirkland & Ellis LLP served as legal counsel. Guggenheim Securities acted as financial advisor to Teleflex and Holland & Knight LLP is served as legal counsel.